메뉴 건너뛰기




Volumn 78, Issue 4, 2005, Pages 441-443

The CYP2C9 genotype does not influence sildenafil pharmacokinetics in healthy volunteers [3]

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; DRUG METABOLITE; N NORSILDENAFIL; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; UNCLASSIFIED DRUG; WATER;

EID: 25844472619     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2005.08.005     Document Type: Letter
Times cited : (7)

References (5)
  • 1
    • 0034029120 scopus 로고    scopus 로고
    • In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions
    • J.S. Warrington, R.I. Shader, L.L. von Moltke, D.J. Greenblatt In vitro biotransformation of sildenafil (Viagra) identification of human cytochromes and potential drug interactions Drug Metab Dispos 28 2000 392 397
    • (2000) Drug Metab Dispos , vol.28 , pp. 392-397
    • Warrington, J.S.1    Shader, R.I.2    Von Moltke, L.L.3    Greenblatt, D.J.4
  • 2
    • 0035039489 scopus 로고    scopus 로고
    • Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil
    • R. Hyland, E.G.H. Roe, B.C. Jones, D.A. Smith Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil Br J Clin Pharmacol 51 2001 239 248
    • (2001) Br J Clin Pharmacol , vol.51 , pp. 239-248
    • Hyland, R.1    Roe, E.G.H.2    Jones, B.C.3    Smith, D.A.4
  • 5
    • 11844304376 scopus 로고    scopus 로고
    • Clinical consequences of cytochrome P450 2C9 polymorphisms
    • J. Kirchheiner, J. Brockmöller Clinical consequences of cytochrome P450 2C9 polymorphisms Clin Pharmacol Ther 77 2005 1 16
    • (2005) Clin Pharmacol Ther , vol.77 , pp. 1-16
    • Kirchheiner, J.1    Brockmöller, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.